Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 662 is a member of the C2H2-type zinc finger protein family and functions as a DNA-binding transcription factor predicted to regulate transcription via RNA polymerase II. The protein is encoded by the ZNF662 gene in humans and is primarily localized to the nucleus, where it likely participates in modulating the expression of specific genetic elements. Although zinc finger proteins, in general, are associated with diverse cellular processes such as DNA recognition, transcriptional activation, and regulation of apoptosis, there is currently no evidence that ZNF662 itself is a recognized therapeutic target or directly linked to specific diseases or interacting drugs[2][4][7][8][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 662 (ZNF662).